Sesamin and sesamolin potentially inhibit adipogenesis through downregulating the peroxisome proliferator-activated receptor γ protein expression and activity in 3T3-L1 cells-Reference-Cited by-同舟云学术

Sesamin and sesamolin potentially inhibit adipogenesis through downregulating the peroxisome proliferator-activated receptor γ protein expression and activity in 3T3-L1 cells

Published:2024-03 Issue: Volume:123 Page:4-17
ISSN:0271-5317
Container-title:Nutrition Research
language:en
Short-container-title:Nutrition Research

Author:

Gina Nelma Nyvonne Tiqu^ORCID,Kuo Jui-Ling,Wu Mei-Li,Chuang Show-Mei

Funder

National Science and Technology Council

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference49 articles.

1. PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease;Corona;Free Radic Biol Med,2016

2. PPARγ signaling and emerging opportunities for improved therapeutics;Wang;Pharmacol Res,2016

3. Peroxisome proliferator-activated receptor γ and C/EBPα synergistically activate key metabolic adipocyte genes by assisted loading;Madsen;Mol Cell Biol,2014

4. Revisiting PPARγ as a target for the treatment of metabolic disorders;Choi;BMB Reports,2014

5. Sesamum indicum L. (sesame) in 2nd century BC Pompeii, southwest Italy, and a review of early sesame finds in Asia and Europe;Zech-Matterne;Veg His. Archaeobot,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sesamolin suppresses adipocyte differentiation through Keap1-dependent Nrf2 activation in adipocytes;Nutrition Research;2024-08

2. Exploiting Spinach‐Derived Extracellular Vesicles for Anti‐Obesity Therapy Through Lipid Accumulation Inhibition;Advanced Therapeutics;2024-07-05